WO2024220709A2 - Fluid injector system with dual display arrangement - Google Patents

Abstract

A fluid injector system having a dual display arrangement is described. The fluid injector system includes a primary display device located inside a sterile field in an angiography suite and an overlay display device positioned in proximity to a fluid injector of the fluid injector system and located outside of the sterile field. The primary display device includes a primary user interface that provides certain control functionality for a fluid injector and is operable by a user within the sterile field, and the overlay display device is associated with the primary display device and includes an overlay user interface that provides control functionality for the fluid injector and is operable by a user outside of the sterile field.

Description

Attorney Ref. No. BHC239009 WO FLUID INJECTOR SYSTEM WITH DUAL DISPLAY ARRANGEMENT CROSS-REFERENCE TO RELATED APPLICATION [0001] This application claims the benefit of U.S. Provisional Patent Application No.63/497,249, filed 20 April 2023, the disclosure of which is incorporated by reference in its entirety. BACKGROUND Field of the Disclosure [0002] The present disclosure relates to fluid injector systems having dual display arrangements for management of fluid injection procedures. In particular, the disclosure relates to dual display fluid injector systems in which a primary display is located within a sterile field and an overlay display is located outside of the sterile field, which allows for easier, safer, and more accurate management of fluid injection procedures. Description of Related Art [0003] An injection system, such as a fluid injector system (e.g., a medical fluid delivery system) may be used by a medical practitioner in a medical diagnostic procedure and/or a medical therapeutic procedure. For example, the medical practitioner may use the fluid injector system to inject a patient with one or more medical fluids. The fluid injector system may be used for pressurized injection of a medical fluid, such as a radiological contrast material (e.g., a contrast agent, contrast media, etc.), and/or a flushing agent, such as saline, in medical imaging procedures, such as angiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and positron emission tomography (PET). A fluid injector system may also be used to deliver medical fluids or liquid medicaments to a patient during other procedures and/or treatments, including nuclear medicine imaging, molecular imaging, radiopharmaceutical injection, and cardiovascular localized therapy. In some instances, a fluid injector system is designed to deliver a preset amount of one or more medical fluids at a preset pressure and/or flow rate. [0004] In some instances, fluid injectors have at least one drive member, such as a piston, that connects to a syringe of the fluid injector, for example via connection with a plunger. The syringe may include a rigid barrel with the syringe plunger being slidably disposed within the barrel. The drive members drive the plungers in a proximal and/or Attorney Ref. No. BHC239009 WO distal direction relative to a longitudinal axis of the barrel to draw fluid into or deliver the fluid from the syringe barrel. [0005] In some instances fluid injector systems may include one screen and/or user interface associated with the fluid injector for managing a fluid injection procedure or for controlling functionality of the fluid injector system. The screen/user interface is typically within the injection suite next to the patient. However, such an arrangement may limit a physician’s ability to easily and accurately manage a fluid injection procedure in response to real-time events during an angiography procedure. In particular, the physician may be in the sterile field and the screen/user interface may be outside of the sterile fluid, such that the physician cannot interact with the screen/interface without risk of contamination. While the physician may instruct a colleague outside of the sterile field regarding changes to an injection procedure, this set-up is inefficient and may result in delays or errors during an angiography procedure, potentially placing the patient’s health at risk. Further, inclusion of a screen/user interface in certain locations may pose risks associated with maintaining sterility in light of potential contamination of the various fluid injector system components and associated devices. [0006] In view of the foregoing, there exists a need for dual display fluid injectors systems in which a primary display is located within a sterile field and an overlay display is located outside of the sterile field, which allows for easier, safer, and more accurate management of fluid injection procedures. SUMMARY [0007] Accordingly, aspects of the present disclosure are directed to non-limiting embodiments of a fluid injector system having a dual display arrangement for management of fluid injection procedures, in which a primary display is located in a sterile field and an overlay display is located outside of the sterile field. [0008] According to an aspect of the disclosure, a fluid injector system having a dual display arrangement includes a primary display device, located inside a sterile field of an angiography suite, and an overlay display device positioned in proximity to the fluid injector of the fluid injector system and located outside of the sterile field. The primary display device includes a primary user interface that provides control functionality for a fluid injector, and the overlay display device is associated with the primary display device and includes an overlay user interface that provides control functionality for the fluid injector. The overlay user interface includes one or more Attorney Ref. No. BHC239009 WO elements that provide the same control functionality for the fluid injector as one or more elements of the primary user interface. [0009] According to another aspect of the disclosure, a fluid injector system includes a fluid injector, a primary display device in communication with the fluid injector, and an overlay display device in communication with the fluid injector and in communication with the primary display device. The primary display device includes a primary user interface that provides control functionality for the fluid injector, and the primary display device is configured to be located inside or outside of a sterile field of an angiography suite. The overlay display device is positioned in proximity to the fluid injector and is located outside the sterile field. The overlay display device includes an overlay user interface that provides control functionality for the fluid injector, and the overlay user interface includes one or more elements that provide the same control functionality for the fluid injector as one or more elements of the primary user interface. [0010] According to another aspect of the disclosure, a fluid injector system includes a primary display device in communication with a fluid injector, an overlay display device in communication with the fluid injector and in communication with the primary display device, and a secondary display device in communication with the primary display device and in communication with the overlay display device. The primary display device is located inside a sterile field and includes a primary user interface having one or more elements that provide control functionality for the fluid injector. The overlay display device is positioned in proximity to a fluid injector, and the overlay display device is located inside of a non-sterile field. The overlay display device includes an overlay user interface that provides control functionality for the fluid injector, and the overlay user interface includes one or more elements that provide the same control functionality for the fluid injector as the one or more elements of the primary user interface. The secondary display device is located outside of the sterile field, and the secondary display device includes a secondary user interface, and the secondary user interface includes one or more secondary display elements. [0011] Non-limiting illustrative examples of embodiments of the present disclosure will now be described in the following numbered clauses. [0012] Clause 1: A fluid injector system, the fluid injector system comprising: a primary display device, wherein the primary display device is located inside a sterile field of an angiography suite, wherein the primary display device comprises a primary user interface that provides control functionality for a fluid injector; and an overlay Attorney Ref. No. BHC239009 WO display device associated with the primary display device, wherein the overlay display device is positioned in proximity to the fluid injector of the fluid injector system, wherein the overlay display device is located outside of the sterile field, wherein the overlay display device comprises an overlay user interface that provides control functionality for the fluid injector, and wherein the overlay user interface comprises one or more elements that provide the same control functionality for the fluid injector as one or more elements of the primary user interface. [0013] Clause 2: The fluid injector system of clause 1, wherein the overlay user interface of the overlay display device comprises at least one element that can be disabled such that the at least one element is non-functional with regard to control functionality for the fluid injector. [0014] Clause 3: The fluid injector system of clause 1 or 2, wherein the primary user interface of the primary display device comprises at least one element that can be disabled such that the at least one element is non-functional with regard to control functionality for the fluid injector. [0015] Clause 4: The fluid injector system of any of clauses 1-3, wherein the overlay user interface of the overlay display device comprises at least one element that is disabled such that the at least one element is non-functional with regard to control functionality for the fluid injector, and the primary user interface comprises a primary user interface element that corresponds to the disabled at least one element of the overlay user interface, and wherein the primary user interface element is enabled with regard to control functionality for the fluid injector. [0016] Clause 5: The fluid injector system of any of clauses 1-4, wherein the primary user interface of the primary display device comprises at least one element that is disabled such that the at least one element is non-functional with regard to control functionality for the fluid injector, and the overlay user interface comprises an overlay user interface element that corresponds to the disabled at least one element of the primary user interface, and wherein the overlay user interface element is enabled with regard to control functionality for the fluid injector. [0017] Clause 6: The fluid injector system of any of clauses 1-5, wherein the overlay user interface of the overlay display device is a graphical user interface (GUI), and wherein the at least one element of the overlay user interface comprises at least one GUI element. Attorney Ref. No. BHC239009 WO [0018] Clause 7: The fluid injector system of any of clauses 1-6, wherein the primary user interface of the primary display device is a graphical user interface (GUI), and wherein the at least one element of the primary user interface comprises at least one GUI element. [0019] Clause 8: The fluid injector system of any of clauses 1-7, wherein the at least one element of the overlay user interface comprises at least one physical button. [0020] Clause 9: The fluid injector system of any of clauses 1-8, wherein the at least one element of the primary user interface comprises at least one physical button. [0021] Clause 10: The fluid injector system of any of clauses 1-9, wherein the overlay display device is positioned on or within a range of 1 foot to 5 feet of the fluid injector. [0022] Clause 11: The fluid injector system of any of clauses 1-10, wherein the overlay display device is positioned on a housing of the fluid injector and the primary display device is positioned on an articulable arm connected to a stand for the fluid injector. [0023] Clause 12: The fluid injector system of any of clauses 1-11, wherein the fluid injector system further comprises a secondary display device in communication with the fluid injector. [0024] Clause 13: The fluid injector system of any of clauses 1-12, the fluid injector system comprising: a fluid injector; a primary display device in communication with the fluid injector, wherein the primary display device comprises a primary user interface that provides control functionality for the fluid injector, wherein the primary display device is configured to be located inside or outside of a sterile field of an angiography suite; and an overlay display device in communication with the fluid injector and in communication with the primary display device, wherein the overlay display device is positioned in proximity to the fluid injector, wherein the overlay display device is located outside the sterile field, and wherein the overlay display device comprises an overlay user interface that provides control functionality for the fluid injector, wherein the overlay user interface comprises one or more elements that provide the same control functionality for the fluid injector as one or more elements of the primary user interface. [0025] Clause 14: The fluid injector system of any of clauses 1-13, wherein the primary display device is located inside of the sterile field. Attorney Ref. No. BHC239009 WO [0026] Clause 15: The fluid injector system of any of clauses 1-14, wherein the fluid injector system further comprises: a fluid injector housing, a stand, at least one syringe; at least one drive member; at least one administration line; and at least one controller. [0027] Clause 16: The fluid injector system of any of clauses 1-15, wherein the overlay display device is positioned on the fluid injector housing. [0028] Clause 17: The fluid injector system of any of clauses 1-16, wherein the overlay display device further comprises a sensor for sensing an orientation of the fluid injector, and wherein the overlay display device adjusts an orientation of the overlay user interface based on the orientation of the fluid injector such that the overlay user interface is readable by a user. [0029] Clause 18: The fluid injector system of any of clauses 1-17, wherein the primary display device is removably attached to an articulable arm. [0030] Clause 19: The fluid injector system of any of clauses 1-18, wherein the articulable arm is positioned on the stand of the fluid injector system. [0031] Clause 20: The fluid injector system of any of clauses 1-19, wherein the articulable arm is positioned on a rail of a patient table. [0032] Clause 21: The fluid injector system of any of clauses 1-20, wherein the overlay display device is removably attached to a second articulable arm, and the articulable arm of the primary display device and the second articulable arm of the overlay display device are attached to a common mounting point of the rail of the patient table. [0033] Clause 22: The fluid injector system of any of clauses 1-21, wherein the primary display device further comprises a sensor for sensing the angle of articulation of the articulable arm, and wherein the sensor of the primary display device determines whether the primary display device is inside of the sterile field or outside of the sterile field based on the angle of articulation. [0034] Clause 23: The fluid injector system of any of clauses 1-22, wherein when the sensor of the primary display device determines the primary display device is located inside of the sterile field, the primary display device initiates execution of at least one Guided Workflow on the primary user interface for a display device located inside of a sterile field. [0035] Clause 24: The fluid injector system of any of clauses 1-23, wherein when the sensor of the primary display device determines the primary display device is Attorney Ref. No. BHC239009 WO located outside of the sterile field, the primary display device initiates execution of at least one Guided Workflow on the primary user interface for a display device located outside of a sterile field. [0036] Clause 25: The fluid injector system of any of clauses 1-24, wherein at least one element of the primary user interface of the primary display device is configured for manual input depending on whether the primary display device is located inside of the sterile field or outside of the sterile field, and wherein the manual input initiates execution of at least one Guided Workflow on the primary user interface based on the manual input depending on whether the primary display is located inside of the sterile field or outside of the sterile field. [0037] Clause 26: The fluid injector system of any of clauses 1-25, comprising: a primary display device in communication with a fluid injector, wherein the primary display device is located inside a sterile field, wherein the primary display device comprises a primary user interface having one or more elements that provide control functionality for the fluid injector; an overlay display device in communication with the fluid injector, wherein the overlay display device is in communication with the primary display device, wherein the overlay display device is positioned in proximity to the fluid injector, wherein the overlay display device is located inside of a non-sterile field, and wherein the overlay display device comprises an overlay user interface that provides control functionality for the fluid injector, wherein the overlay user interface comprises one or more elements that provide the same control functionality for the fluid injector as the one or more elements of the primary user interface; and a secondary display device in communication with the primary display device and in communication with the overlay display device, wherein the secondary display device is located outside of the sterile field, wherein the secondary display device comprises a secondary user interface, and wherein the secondary user interface comprises one or more secondary display elements. [0038] Clause 27: The fluid injector system of any of clauses 1-26, wherein the secondary display device is located outside of the sterile field and outside of the non- sterile field. [0039] Clause 28: The fluid injector system of any of clauses 1-27, wherein at least one secondary display element of the one or more secondary display elements can be disabled such that the at least one secondary display element is non-functional with regard to control functionality for the fluid injector. Attorney Ref. No. BHC239009 WO [0040] Clause 29: The fluid injector system of any of clauses 1-28, wherein the at least one secondary display element of the one or more secondary display elements can be disabled such that the at least one secondary display element is non-functional with regard to control functionality for the fluid injector, and the primary user interface comprises a primary user interface element that corresponds to the disabled at least one secondary display element, and wherein the primary user interface element is enabled with regard to control functionality for the fluid injector. [0041] Clause 30: The fluid injector system of any of clauses 1-29, wherein at least one secondary display element of the one or more secondary display elements is enabled such that the at least one secondary display element is functional with regard to input of values or information of at least one of a medical fluid, an injection parameter, and a patient relevant to an injection procedure. [0042] Clause 31: The fluid injector system of any of clauses 1-30, wherein the secondary display device is located in an angiography suite. [0043] Clause 32: The fluid injector system of any of clauses 1-31, wherein the secondary display device is located in a control room. [0044] Clause 33: The fluid injector system of any of clauses 1-32, wherein the secondary display device is removably attached to an articulable arm and the articulable arm is positioned on a stand. [0045] Further details and advantages of the various examples described in detail herein will become clear upon reviewing the following detailed description of the various examples in conjunction with the accompanying drawing figures. BRIEF DESCRIPTION OF THE DRAWINGS [0046] Additional advantages and details are explained in greater detail below with reference to the exemplary embodiments that are illustrated in the accompanying figures, in which: [0047] FIG.1 illustrates a non-limiting embodiment of a fluid injector in accordance with the present disclosure; [0048] FIGS. 2A and 2B illustrate non-limiting embodiments of a fluid injector system in accordance with the present disclosure; [0049] FIG.3 is a diagram of a non-limiting embodiment of an environment in which systems and devices associated with a fluid injector system may be implemented in accordance with the present disclosure; Attorney Ref. No. BHC239009 WO [0050] FIGS.4A-4E are diagrams of non-limiting embodiments of a fluid injector system in accordance with the present disclosure; [0051] FIGS.5A and 5B illustrate non-limiting embodiments of display devices and user interfaces of a fluid injector system in accordance with the present disclosure; [0052] FIGS.6A-6F illustrate non-limiting embodiments of a fluid injector system and associated components in a first orientation in accordance with the present disclosure; [0053] FIGS. 7A-7F illustrate non-limiting embodiments of a fluid injector and associated components in a second orientation in accordance with the present disclosure; [0054] FIG.8 illustrates a non-limiting embodiment of an environment in which a fluid injector system may be implemented in accordance with the present disclosure; [0055] FIGS.9A and 9B are diagrams of non-limiting embodiments of a fluid injector system in accordance with the present disclosure; [0056] FIG.10 illustrates a non-limiting embodiments of a user interfaces of a fluid injector system in accordance with the present disclosure; and [0057] FIGS. 11A and 11B illustrate non-limiting embodiments of a secondary display device of a fluid injector system and components thereof in accordance with an aspect of the present disclosure. [0058] Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate exemplary embodiments of the disclosure, and such embodiments are not to be construed as limiting the scope of the disclosure in any manner. DETAILED DESCRIPTION [0059] It is to be understood that the present disclosure may assume various alternative variations and step sequences, except where expressly specified to the contrary. It is also to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification, are simply exemplary and non-limiting embodiments or aspects of the disclosure. Hence, specific dimensions and other physical characteristics related to the embodiments or aspects disclosed herein are not to be considered as limiting unless otherwise indicated. [0060] For purposes of the description hereinafter, the terms “end,” “upper,” “lower,” “right,” “left,” “vertical,” “horizontal,” “top,” “bottom,” “lateral,” “longitudinal,” and derivatives thereof shall relate to embodiments or aspects of the disclosure as they Attorney Ref. No. BHC239009 WO are oriented in the drawing figures. However, it is to be understood that embodiments or aspects may assume various alternative variations and step sequences, except where expressly specified to the contrary. Spatial or directional terms, such as “left”, “right”, “inner”, “outer”, “above”, “below”, and the like, are not to be considered as limiting as the disclosure can assume various alternative orientations. [0061] All numbers used in the specification and claims are to be understood as being modified in all instances by the term “about”. The terms “approximately”, “about”, and “substantially” mean a range of plus or minus ten percent of the stated value. [0062] As used herein, the term “at least one of” is synonymous with “one or more of”. For example, the phrase “at least one of A, B, and C” means any one of A, B, and C, or any combination of any two or more of A, B, and C. For example, “at least one of A, B, and C” includes one or more of A alone; or one or more of B alone; or one or more of C alone; or one or more of A and one or more of B; or one or more of A and one or more of C; or one or more of B and one or more of C; or one or more of all of A, B, and C. Similarly, as used herein, the term “at least two of” is synonymous with “two or more of”. For example, phrase “at least two of D, E, and F” means any combination of any two or more of D, E, and F. For example, “at least two of D, E, and F” includes one or more of D and one or more of E; one or more of D and one or more of F; one or more of E and one or more of F; or one or more of all of D, E, and F. [0063] No aspect, component, element, structure, act, step, function, instruction, and/or the like used herein should be construed as critical or essential unless explicitly described as such. Also, as used herein, the articles “a” and “an” are intended to include one or more items, and may be used interchangeably with “one or more” and “at least one.” As used in the specification and the claims, the singular form of “a,” “an,” and “the” include plural referents, unless the context clearly dictates otherwise. Where only one item is intended, the term “one” or similar language is used. Also, as used herein, the terms “has,” “have,” “having,” or the like are intended to be open- ended terms. Further, the phrase “based on” is intended to mean “based at least partially on” unless explicitly stated otherwise. Further, the phrase “based on” is intended to mean “based at least partially on” unless explicitly stated otherwise. [0064] When used in relation to a component of a fluid injection system such as a fluid reservoir, a syringe, or a fluid line, the term “distal” refers to a portion of said component nearest to a patient. When used in relation to a component of a fluid injection system such as a fluid reservoir, a syringe, or a fluid line, the term “proximal” Attorney Ref. No. BHC239009 WO refers to a portion of said component nearest to the injector of the fluid injection system (i.e. the portion of said component farthest from the patient). When used in relation to a syringe of a multi-patient disposable set, the term “proximal” refers to a portion of a syringe nearest a piston for delivering fluid from a syringe. When used in relation to a component of a fluid injection system such as a fluid reservoir, a syringe, or a fluid line, the term “upstream” refers to a direction away from the patient and towards the injector of the fluid injection system. When used in relation to a component of a fluid injection system such as a fluid reservoir, a syringe, or a fluid line, the term “downstream” refers to a direction towards the patient and away from the injector of the fluid injection system. [0065] As used herein, the terms “communication” and “communicate” may refer to the reception, receipt, transmission, transfer, provision, and/or the like of information (e.g., data, signals, messages, instructions, commands, and/or the like). For one unit (e.g., a device, a system, a component of a device or system, combinations thereof, and/or the like) to be in communication with another unit means that the one unit is able to directly or indirectly receive information from and/or transmit information to the other unit. This may refer to a direct or indirect connection that is wired and/or wireless in nature. Additionally, two units may be in communication with each other even though the information transmitted may be modified, processed, relayed, and/or routed between the first and second unit. For example, a first unit may be in communication with a second unit even though the first unit passively receives information and does not actively transmit information to the second unit. As another example, a first unit may be in communication with a second unit if at least one intermediary unit (e.g., a third unit located between the first unit and the second unit) processes information received from the first unit and communicates the processed information to the second unit. In embodiments, a message may refer to a network packet (e.g., a data packet and/or the like) that includes data. It will be appreciated that numerous other arrangements are possible. [0066] According to various embodiment, the fluid injector system having a dual display configuration provides advantages over conventional single display injector configurations or conventional dual display injector configurations. For example, the dual display configuration allows access by users in the sterile field as well as users in the non-sterile field. As used herein, the “sterile field” is defined as an area around the operating table or imager where the patient undergoes the angiography or other Attorney Ref. No. BHC239009 WO medical procedure and the physician is required to remain in the sterile field and maintain the sterility of themselves and various injection components to prevent inadvertent exposure of the patient or injection components to microbial contamination. As used herein the “non-sterile field” is defined as an area outside the sterile field where inadvertent contamination of the various injection components is not a concern due to the distance between the non-sterile field and the sterile components, sterile personnel, and the patient within the sterile field. [0067] Embodiments of the present disclosure are generally directed to fluid injector systems, which may include a primary display device and an overlay display device. According to various embodiments, the primary display device may be located inside or moveable to inside of a sterile field of an angiography suite, and may include a primary user interface that provides control functionality for a fluid injector. The overlay display device may be associated with the primary display device and may be positioned in proximity to the fluid injector of the fluid injector system. The overlay display device may be located outside of the sterile field and may include an overlay user interface that provides control functionality for the fluid injector. The overlay user interface may include one or more elements that provide the same control functionality for the fluid injector as one or more elements of the primary user interface. In addition, according to certain embodiments, the primary display device and/or the secondary display device may include one or more elements or functions that are available on only either the primary display device or only on the secondary display device. [0068] In this way, embodiments of the present disclosure pertain to dual display fluid injector systems in which a primary display is located within the sterile field, for example the sterile field of an angiography suite, and an overlay display is located outside of the sterile field, which allows for easier, safer, and more accurate management of fluid injection and medical imaging procedures concurrent with associated medical procedures. For example, the dual display injector systems described herein may be used during an angiography procedure, such as installation of a stent in a blood vessel of the heart, wherein the physician may be within the sterile field and may need to conduct and/or adjust various inputs associated with a contrast fluid injection procedure in real-time during the angiography procedure. The physician may make the necessary adjustments or inputs on the sterile primary display within the sterile field without any potential contamination events. Attorney Ref. No. BHC239009 WO [0069] The present disclosure is generally described in connection with pressurized injection of a medical fluid such as radiological contrast material and/or a flushing agent in procedures such as angiography (CV), computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), X-ray, and positron emission tomography (PET). However, it is to be understood that the devices, systems, and methods described herein may also be used in other applications where intravenous injection of medical fluids, therapeutic agents, medicaments, drugs, and the like is indicated. Further, although the present disclosure may be applied to computed tomography (CT) and/or angiographic-type injection systems, the present description may also be applied in the context of injection systems designed for use in magnetic resonance (MR) imaging procedures. In particular, the present disclosure is described herein, by way of example, in connection with a dual head (a/k/a dual syringe) type system, it will be apparent that the present disclosure may also be used in connection with single head (a/k/a single syringe) type injection systems. [0070] In carrying out an injection procedure, fluid injectors systems may include a series of steps or processes for setting up a fluid injection procedure, priming and preparing the system for the fluid injection procedure, conducting a fluid injection procedure, and preparing the system for a subsequent fluid injection procedure. The series of steps or processes may be long and complex and the potential for skipping or inadvertently missing one or more steps may result in sub-optimal images, potential harm to a patient, and/or require repeating the fluid injection and imaging procedure. Guided Workflow procedures that guide a user through an injection procedure may improve injection procedures and limit mistakes, resulting in better image quality and limit errors or potential harm to a patient. Examples of Guided Workflow procedures that may be executed by fluid injector systems of the present disclosure are described in PCT Application Publication No. WO 2023/215387, the disclosure of which is incorporated in its entirety herein by reference. [0071] To carry out the prescribed series of steps or processes, fluid injectors may include a display device or a screen, such as a computer screen, a tablet, or a work station device, for displaying various injection procedure steps, commands, warnings, or other information regarding the progress of an injection procedure or the fluid injector system. The display device may also include a user interface associated and in communication with a controller of the fluid injector system for managing and carrying out injection procedure steps, inputting or updating data, or for otherwise Attorney Ref. No. BHC239009 WO controlling functionality of the fluid injector system. In some instances, fluid injectors may include a screen and/or interface associated with the fluid injector within the injection suite next to the patient (e.g., within the sterile field), and/or a workstation device associated with the fluid injector system (e.g., outside the sterile field). [0072] Referring to the drawings in which like reference characters refer to like parts throughout the several views thereof, the present disclosure is generally directed to a medical injector/injection system 100 (hereinafter “fluid injector system 100”) for example an injector system including one or more syringes, including front-loading syringes and rolling diaphragm-type syringes. However, the systems, components, devices, and protocols of the present disclosure may be utilized or incorporated into other syringe-based injector systems. [0073] Referring now to FIG.1, a non-limiting embodiment of fluid injector system 100 and fluid injector 102 (i.e., a fluid injector head), associated with fluid injector system 100 in accordance with the present disclosure. Fluid injector system 100 may include a powered injector administrator or device configured to move various components of the injector during an injection protocol and operated by at least one controller or processor, which may include an injection protocol management system, and a fluid delivery set intended to be associated with the powered injector to take in and deliver one or more fluids from one or more fluid reservoirs under pressure into a patient. In one example, fluid injector 102 may include at least one fluid reservoir, such as syringe 140, at least one piston (not shown) having an interface that is reversibly connectable to a plunger of the syringe, and a fluid control module 132. Embodiments and features of suitable syringes are described in PCT Application Publication No. WO 2022/035791, filed 10 August 2021, the disclosure of which is incorporated in its entirety herein by reference. The at least one syringe 140 may be adapted to interface with at least one component of the system, such as a syringe interface 134. The fluid injector 102 may be configured to deliver at least one fluid to a patient during an injection procedure, such as an angiography injection procedure. The fluid injector 102 may be configured to releasably receive the at least one syringe 140, which is to be filled with at least one fluid, such as an imaging contrast media, saline solution, Ringer’s lactate, or any desired medical fluid, supplied by a fluid source through a fluid line. Fluid injector 102 may be a multi-syringe injector, wherein two or more syringes 140 may be oriented side-by-side or other spatial relationship and are separately actuated by respective pistons associated with fluid injector 102. The at least one Attorney Ref. No. BHC239009 WO syringe 140 may be oriented in any manner such as upright, downright, or positioned at any degree angle. [0074] With continued reference to FIG. 1, the fluid injector 102 of fluid injector system 100 may be used during a medical procedure to inject the at least one medical fluid into the vasculature system of a patient by driving a plunger of at least one syringe 140 with a drive member, such as the at least one piston (not shown). The at least one piston may be reciprocally operable upon at least a portion of the at least one syringe 140, such as the plunger. Upon engagement, the at least one piston may move the plunger toward the distal end of the at least one syringe 140, as well as retracting the plunger toward the proximal end of the at least one syringe 140. The syringe 140 may extend along a longitudinal axis. A fluid line may also be connected in fluid communication with a syringe tip of each syringe 140 to place each syringe 140 in fluid communication with a bulk fluid reservoir for filling each syringe 140 with a medical fluid and/or for delivering the fluid from each of syringes 140 to an administration line, and to a catheter (not shown) inserted into a patient at a vascular access site. [0075] In various examples, the syringe retention features of the present disclosure may be suited for use in single or dual syringe-type front-loading fluid injector systems, such as are disclosed in U.S. Patent Nos. 5,383,858, 7,553,294, 7,563,249, 7,666,169, 8,945,051, 9,173,995, 9,199,033, 9,474,857, and 10,124,110, U.S. Patent Application Serial Nos. 15/305,285, 15/541,573, and 15/568,505, and in PCT Application Publication Nos. WO 2016/191485; WO 2016/112163; WO 2020/055785; and WO 2021/050507, the disclosures of which are incorporated in their entireties herein by reference. [0076] With reference to FIG.1, fluid injector 102 may include an injector housing 104 having opposed lateral sides 106, a distal or upper end 108, and a proximal or lower end 110. Housing 104 may enclose the various mechanical drive components, electrical and power components necessary to drive the mechanical drive components, and control components, such as electronic memory and electronic control devices (hereinafter electronic control device(s)), used to control operation of reciprocally movable piston elements associated with the fluid injector system 100 described herein, including communication with a controller or processor. [0077] Fluid injector 102 may include a display device such as a screen. As shown in FIG.1, the display device may be overlay display device 122 and overlay display device 122 may include an overlay user interface 124. The overlay user interface 124 Attorney Ref. No. BHC239009 WO may be a graphical user interface (GUI) display window or touch screen, and may include one or more elements 126, such as buttons and/or readouts. In embodiments where the overlay user interface 124 is a GUI, the one or more elements 126 may be a GUI element. In some embodiments, element 126 of the overlay user interface 124 may be a physical button. In some embodiments, elements such as element 126 associated with a user interface may provide control functionality for the fluid injector 102 and/or the fluid injector system 100. [0078] A user interface such as overlay user interface 124 may display information pertinent to a fluid injection procedure involving the fluid injector system 100, such as current flow rate, fluid pressure, and volume remaining in the fluid sources connected to the fluid injector system 100. In certain embodiments, overlay user interface 124 may be at a touch screen GUI that allows an operator to input commands and/or data for operation of the fluid injector system 100. While the user interface 124 is shown on the injector housing 104, interface 124 may also be in the form of or include an additional remote display that is wired or wirelessly linked to the housing 104 and electrical control devices and mechanical elements of the fluid injector system 100. In some aspects, the user interface 124 may be a tablet computer that is detachably connected to the housing 104 and is in wired or wirelessly linked communication with the housing 104. The fluid injector system 100 may further include one or more processors in electronic communication with and configured to control one or more functions of the fluid injector system 100. [0079] In some non-limiting embodiments, element 126 may be provided as one or more control buttons (e.g., physical buttons or touch screen buttons) for tactile operation by an attendant operator of the fluid injector system 100, such as a button for engaging and disengaging the syringe retention features described herein. In certain aspects, element 126 may be part of a keyboard for inputting commands and/or data by the operator. In some non-limiting embodiments, element 126 may be provided as a physical button in addition to one or more GUI elements provided in overlay user interface 124. In such embodiments, element 126 may be hard-wired or wirelessly connected to the electronic control device(s) associated with the fluid injector system 100 to provide direct input to the electronic control device(s). Element 126 may provide certain individual control features to the attendant operator of the fluid injector system 100, such as but not limited to: (1) filling/purging/priming of the fluid injector system 100; (2) inputting or manipulating information and/or data related Attorney Ref. No. BHC239009 WO to the patient and/or injection procedure, and (3) initiating/stopping an injection procedure. The overlay user interface 124 and/or any electronic processing units associated with the fluid injector system 100 may be wired or wirelessly connected to an operation and/or data storage system such as a hospital information system. In some non-limiting embodiments, fluid injector system 100 may include a microphone, a camera, a motion sensor, or the like for additional or alternative input of a command or information. In such embodiments, the command or information may be inputted via a voice command, a gesture, or the like. [0080] Referring now to FIGS. 2A and 2B, non-limiting embodiments of a dual display configuration of fluid injector system 100 in accordance with the present disclosure are illustrated. FIG.2A illustrates an embodiment of fluid injector system 100 including fluid injector 102 having a fluid path cassette component engagement feature 202 with associated stopcock actuators and air detectors. Examples of suitable fluid path cassette components are described in PCT Application Publication No. WO 2022/119837, the disclosure of which is incorporated in its entirety herein by reference. FIG.2B illustrates an embodiment of injector system 100 including fluid injector 102 having a dual syringe setup and associated syringe engagement features without an associated fluid path cassette component engagement feature. [0081] As shown in FIGS.2A and 2B, a dual display configuration of fluid injector system 100 may include two display devices, primary display device 112 and overlay display device 122. Fluid injector system 100 may also include two user interfaces, primary user interface 114 and overlay user interface 124, which may be in communication with and configured to control fluid injector 102. Each of the primary display device 112 and overlay display device 122 and/or primary user interface 114 and overlay user interface 124 may include one or more elements such as elements 116, 126 which may be GUI elements or physical button elements as discussed herein. For example, primary user interface 114 of primary display device 112 may be a graphical user interface (GUI), and the element 116 of the primary user interface 112 may be a GUI element. [0082] As shown in the exemplary embodiments in FIGS. 2A and 2B, primary display device 112 may be removably attached to and positioned on articulable arm 206 and overlay display device 122 may be positioned on housing 104 of fluid injector 102. Further, fluid injector 102 and/or articulable arm 206 may be positioned on a stand 204. This configuration allows the primary display device 112 to be positioned or Attorney Ref. No. BHC239009 WO located inside of the sterile field, while the overlay display device 122 positioned on the housing may be located outside of the sterile field. In other embodiments, as primary display device 112 may be removably attached, primary display device 112 may be adaptable such that it may be positioned inside the sterile field or outside the sterile field. The setup of the dual display configuration, including positioning each of the primary display 112 and secondary display 122 either inside the sterile field or outside the sterile field may depend on factors including but not limited to site practices, physician/technician preferences, treatment parameters, and space constraints. [0083] As discussed herein, each of the two display screens, primary display device 112 and overlay display device 122, may include primary user interface 114 and overlay user interface 124 respectively, either of which may be a graphical user interface (GUI) comprising a display window or touch screen, and/or one or more buttons and readouts. The two user interfaces may independently or together display information pertinent to a fluid injection procedure involving the fluid injector system, such as current flow rate, fluid pressure, fluid volume administered, and volume remaining in the fluid sources connected to the fluid injector system and other data related to a fluid injection procedure, such as patient data, graphical display of progress of injection procedure. In certain embodiments, one or both of the two user interfaces may be a touch screen GUI that allows operators to independently input commands and/or data for operation of the fluid injector system via either of the two user interfaces. In certain embodiments, certain commands and/or data may only be inputted on one of the two user interfaces or may be inputted on either of the two user interfaces. In various embodiments, input and/or data inputted on one of the two user interfaces will be observable and/or modifiable on the second of the two user interfaces. [0084] Referring now to FIG. 3, a diagram of a non-limiting embodiment of environment 300 is shown in which systems and devices associated with fluid injector system 100 may be implemented in accordance with the present disclosure. As shown in FIG.3, environment 300 may include fluid injector system 100, injection protocol management system 302, communication network 304, hospital information system 306, primary display device 112, and overlay display device 122. Fluid injector system 100, injection protocol management system 302, primary display device 112, overlay display device 122, and/or hospital information system 306, may interconnect via wired Attorney Ref. No. BHC239009 WO connections, wireless connections, or a combination of wired and wireless connections, for example, as shown in FIGS.8, 11A and 11B. [0085] A shown in FIG.3, in certain embodiments, injection protocol management system 302 may be an electronic control device and may include a processor to, or is operable to, execute appropriate custom-designed or conventional software to perform and implement the processing steps of the embodiments of the methods and systems of the present disclosure, thereby forming a specialized and particular computing system. Accordingly, the presently-disclosed methods and systems may include one or more electronic control devices or similar computing devices having a computer-readable storage medium capable of storing computer-readable program code or instructions that cause the processing unit to execute, configure, or otherwise implement the methods, processes, and transformational data manipulations discussed hereinafter in connection with the present disclosure. [0086] With continued reference to FIG.3, injection protocol management system may include one or more devices capable of being in communication with one or more of fluid injector system 100, primary display device 112, overlay display device 122, and/or hospital information system 306, via communication network 304. For example, injection protocol management system 302 may include one or more computing devices, such as one or more computers, one or more controllers, one or more servers, one or more desktop computers, one or more mobile devices, and/or the like. Injection protocol management system 302 may include one or more software and/or hardware applications that perform a set of functionalities on an external application programming interface (API) that allows injection protocol management system 302 to send data to an external system associated with the external API and to receive data from the external system associated with the external API. In some embodiments, the application may be supported by an application associated with fluid injector system 100 that allows injection protocol management system 302, e.g., via primary display device 112 within a sterile field, to be the only one device that controls fluid injector system 100 and, in such an example, injection protocol management system 302 may provide an authentication function. In some non-limiting embodiments, injection protocol management system 302 may be a component of fluid injector system 100, primary display device 112, and/or overlay display device 122. [0087] In some embodiments, fluid injector system 100 may include one or more devices capable of being in communication with injection protocol management Attorney Ref. No. BHC239009 WO system 302, primary display device 112, overlay display device 122, and/or hospital information system 306 via communication network 304. Fluid injector system 100 may include one or more fluid injection devices, such as fluid injector 102, configured to administer a contrast agent to a patient, and/or administer an aqueous flushing fluid, such as saline, to a patient before, during, and/or after administering the contrast fluid. In embodiments, fluid injector system 100 may include one or more exemplary fluid injector devices that are disclosed in: U.S. Patent No. 6,643,537; U.S. Patent No. 7,094,216; U.S. Patent No. 7,556,619; U.S. Patent No. 8,337,456; U.S. Patent No. 8,147,464; U.S. Patent No. 8,540,698, U.S. Patent No. 9,173,995, U.S. Patent No. 10,507,319, and PCT Application Publication Nos. WO 2022/119837 and WO 2022/182935, the disclosures of each of which are incorporated by reference herein in their entireties. In embodiments, fluid injector system 100 described herein may be or include components of, but are not limited to, the Bayer MEDRAD® Stellant CT Injection System, the Bayer MEDRAD® Stellant FLEX CT Injection System, the Bayer MEDRAD® MRXperion MR Injection System, the Bayer MEDRAD® Mark 7 Arterion Injection System, the Bayer MEDRAD® Avanta Injection System, the Bayer MEDRAD® Intego PET Infusion System, the Bayer MEDRAD® Centargo CT Injection System, or other Bayer sourced injector systems used for angiography, magnetic resonance imaging, and computed tomography all of which are provided by Bayer Healthcare LLC. The various embodiments described herein may also be implemented with other commercially available fluid injector systems without deviating from the scope of the disclosure. [0088] In embodiments, fluid injector system 100 may include one or more sensing mechanisms, such as one or more sensors, that allow injection protocol management system 302 and/or fluid injector system 100 to detect when a step of a Guided Workflow has been initiated, in progress, and/or completed. Injector management system 102 and/or fluid injector system 104 may notify a user of a subsequent step to be completed in a sequence of a Guided Workflow. The one or more sensors may also be configured to determine if a specific step of a Guided Workflow has been successfully completed before moving to a subsequent step in the sequence of the Guided Workflow. If injection protocol management system 302 and/or fluid injector system 100 detects that a step has not been successfully completed or has been skipped, a warning notification may be provided, for example on primary user interface 114 and/or overlay user interface 124, such as by illumination of one or more warning Attorney Ref. No. BHC239009 WO lights (e.g., a red light at or near features associated with a specific step), and/or one or more audible, visual, or tactile warning alerts to the user to indicate that the step has not been correctly completed and any error must but corrected before the Guided Workflow can progress to a subsequent step. Similarly In some non-limiting embodiments, the one or more sensors may include switches, buttons, light sensors, motion sensors, accelerometers, air detectors and the like. For example, an accelerometer may be implemented to detect changes in orientation of primary display device 112 and/or overlay display device 122, movement of articulable arm 206 and/or stand 204, and/or other positioning of fluid injector 102, for example wherein such changes in orientation may be associated with performing or completion of a step in a Guided Workflow. [0089] In embodiments, primary display device 112 and/or overlay display device 122 may include one or more devices capable of being in communication with injection protocol management system 302, fluid injector system 100, and/or hospital information system 306 via communication network 304. For example, primary display device 112 and/or overlay display device 122 may include a computing device, such as one or more computers, including a desktop computer, a laptop, tablet, and/or the like. In certain embodiments, at least a portion of the processes executed via primary display device 112 and/or overlay display device 122 may be executed at a remote server. Primary display device 112 and/or overlay display device 122 may provide a user interface such as primary user interface 114 and/or overlay user interface 124 for controlling operation of fluid injector system 100, including to generate instructions for and/or provide instructions to fluid injector system 100. Primary display device 112 and/or overlay display device 122 may further display operational parameters of fluid injector system 104 during operation (e.g., during real-time operation) of fluid injector system 100. In various embodiments, primary display device 112 and/or overlay display device 122 may provide interconnectivity between fluid injector system 104 and other devices or systems. For example, primary display device 112 and/or overlay display device 122 may include a computer monitor, touchscreen, a heads-up display, a wireless handheld device (e.g., smart pad, smart watch, smart phone, etc.), and/or the like, that may be used to display a user interface (e.g., a graphical user interface (GUI) of a software application), via which a user may interact to view parameters and/or control operation of fluid injector system 100 and/or imaging system. Attorney Ref. No. BHC239009 WO [0090] With continued reference to FIG.3, hospital information system 306 may include one or more devices capable of being in communication with a medical imaging system, injection protocol management system 302, fluid injector system 100, primary display device 112 and/or overlay display device 122 via communication network 304. Hospital information system 306 may include one or more subsystems, such as a patient procedure tracking system (e.g., a system that operates a modality worklist, a system that provides patient demographic information for fluid injection procedures and/or medical imaging procedures, etc.), a fluid injection management system, an image archive and communication system (e.g., a picture archive and communication system (PACS)), a radiology information system (RIS), and/or a radiology analytics system (e.g., the Radimetrics® Enterprise Application marketed and sold by Bayer HealthCare LLC). Hospital information system 306 may include one or more databases that stores patient records therein, which may be accessed by devices or systems in environment 300. [0091] The number and arrangement of systems and/or devices shown in FIG.3 are provided as an example. There may be additional systems and/or devices, fewer systems and/or devices, different systems and/or devices, or differently arranged systems and/or devices than those shown in FIG.3. [0092] Referring now to FIGS.4A-4E, diagrams of non-limiting embodiments of fluid injector system 100 in accordance with the present disclosure are illustrated. As shown in FIGS.4A-4E, fluid injector system 100 may include primary display device 112, and the primary display device 112 may be located inside of a sterile field. Primary display device 112 may include a primary user interface 114 that provides control functionality for a fluid injector. Further, overlay display device 122 may be associated with primary display device 112, such that they are configured to communicate with each other. [0093] In some embodiments fluid injector system 100 may be implemented in a “use case” where both the primary display 112 and the overlay display 122 are used by the non-sterile personnel in the non-sterile field. In such an embodiment, a non- sterile user may input, adjust, or control features and options that are available on each of the two display units without concern of contamination of the sterile field. For example, in a scenario between fluid injection procedures or before the first or after the last fluid injection procedure, a non-sterile user may input values or fluid injection protocols, change values, access results, or otherwise manipulate data or information of either of the two display units, without potential contamination of the sterile field. Attorney Ref. No. BHC239009 WO [0094] In some embodiments, fluid injector system 100 may be implemented in a “use case” where one display such as primary display device 112 may be located within the sterile field and the other display such as overlay display device 122 may be located outside the sterile field. According to these embodiment, the display within the sterile field may be accessed and manipulated (data values inputted, etc.) by a sterile personnel or physician, for example, during an angiography procedure, and the display in the non-sterile field may be accessed and manipulated by a non-sterile personnel or technician/physician. Sterile personnel will typically be physicians tasked with attending to a patient on a patient table during an injection procedure or execution of an injection protocol and angiography procedure, e.g., inserting and manipulating a catheter or guide wires in the patient’s vasculature. During a procedure, the sterile physician may need to manipulate or input one or more injection parameters in real- time, for example with minor adjustments of fluid pressure or flow rates and may do so via primary display device 112 in the sterile field without concern of contamination of the sterile field. According to these embodiments, the present dual display configuration may be more expedient compared to instructing personnel outside the sterile field next to fluid injector 102 to make the needed adjustments. Non-sterile personnel will typically be those technicians tasked with operating the fluid injector or adjusting the injection protocol values by inputting the required information or numbers directly onto the non-sterile display, such as overlay display 122 and will not necessarily be aware of any real-time adjustments necessary for the on-going angiography procedure. [0095] Accordingly, in some non-limiting embodiments, overlay display device 122 may be positioned in proximity to a fluid injector of the fluid injector system, and may be located outside of the sterile field. Overlay display device 122 may include overlay user interface 124 that provides control functionality for fluid injector 102, and overlay user interface 124 may include one or more elements 126 that provide the same control functionality for fluid injector 102 as one or more elements 116 of primary user interface 114. As shown for example in FIGS.4B-4E, overlay display 122 may be positioned on a head of fluid injector 102, such as on the fluid injector head or housing (e.g., housing 104, FIG.1). In some non-limiting embodiments, as shown for example in FIG.4A, overlay display device may not be provided on fluid injector 102, but may be positioned next to the fluid injector 102, for example within a range of 0.5 foot to 5 feet of fluid injector 12 associated with fluid injector system 100 such that it is in the Attorney Ref. No. BHC239009 WO non-sterile field. In such non-limiting embodiments, the primary display device 112 may be used by the sterile personnel within the sterile field and the overlay display device 122 may be used by the non-sterile personnel in the non-sterile field. For example the primary display device 112 may be covered with a sterile sheath or other protective feature to maintain the sterility of the display, whereas the overlay display 122 may not be covered or otherwise protected to maintain sterility of injector features. [0096] According to various embodiments, the dual display configuration of fluid injector system 100 provides for when the primary display 112 is used in the sterile field and covered with a sterile sheath, the non-sterile personnel in the non-sterile field will not be able to touch the primary display 112 in order to tell the injector to fill more fluids, etc. Therefore, a non-sterile overlay display 122 is configured for scenarios that while the primary display 112 is in the sterile field, the non-sterile personnel will be able to manipulate the fluid injector via the overlay display 122 to operate and initiate a fluid injection protocol and take care of that task while the sterile personnel attends to the patient and their needs on the table during the injection setup and procedure, e.g., inserting and manipulating a catheter or guide wires in the patient’s vasculature. In other embodiments, the injector head of fluid injector 102 may include a sterile sheath, such that the overlay display 122 is within the sterile field and the primary display 112 may be in the non-sterile field. In other embodiments, both the primary display 112 and the overlay display 122 may be within the sterile field and their sterility maintained, for example by a sterile sheath. [0097] In various embodiments, the two displays may be configured to display and allow the associated user to access options and features associated with an injection protocol and procedure. In other cases, the two displays may be configured to display or allow the associated user to manipulate different values available to the user of the other display. For example, the primary display 112 may be the display within the sterile field and may be operated by the physician or personnel conducting an angiography procedure or other imaging procedure. The primary display 112 in the sterile field may include primary user interface 114 such as a touch screen feature that may allow the sterile personnel to access all options and features available on the injector, such as, but not limited to adjusting injection protocol parameters, configuring injector settings, visualize fluid flow rates, etc. The overlay display 122 may be the display in the non-sterile field and may be operated by the radiologist, technician, or other non-sterile personnel during the angiography procedure or other imaging Attorney Ref. No. BHC239009 WO procedure. The overlay display 122 may include user interface 124 such as a touch screen feature that allows the user to access tasks associated with a fluid injector protocol, such as, but not limited to, filling the syringe(s) with contrast or saline flushing agent, purging and priming the syringe and fluid path components prior to initiation of the fluid injection procedure, confirming completion of a priming procedure and ensuring no air is in the fluid path, arming the injector once the syringes and fluid paths are appropriately primed, and refilling a syringe mid-patient should additional contrast agent or saline be needed to complete a fluid injection protocol. In certain embodiments, input or manipulation of certain parameters or injector settings may be limited to only either the primary display 112 or the overlay display 122. For example, certain protocol parameters may only be manipulated by the physician in the sterile field via the primary display 112, whereas other protocol parameters may only be manipulated by personnel in the non-sterile field via the overlay display 122. Other protocol parameters may be manipulated on either of the primary display 112 and the overlay display 122. In other embodiment, the ability of adjust certain injection protocol parameters may be selectively locked out of one of the primary display 112 or the overlay display 122 during a procedure, for example to prevent inadvertent adjustment or changing of the parameter. In certain embodiments, if certain commands are accessed on one screen to manually move the syringe pistons, the auto purge/auto fill features on the other screen may be locked out to prevent unsafe actions from occurring. [0098] As further illustrated in FIG.4A, element 126 of overlay user interface 124 and element 116 of primary user interface 114 may correspond to each other such that they provide the same control functionality for fluid injector 102 and fluid injector system 100. Depending on the control functionality presented or prescribed by one of various steps in a Guided Workflow, both element 126 of overlay user interface 124 and element 116 of primary user interface 114 may be enabled to provide the indicated control functionality. In some non-limiting embodiments, as shown in FIG.4C, both element 126 of overlay user interface 124 and element 116 of primary user interface 114 may be disabled with regard to control functionality, such as by being “grayed out”, covered (such as with diagonal lines as illustrated), or otherwise blocked out. For example, if one or more sensors of fluid injector system 100 detects that one or more components has been incorrectly installed, or a step in a series of a Guided Workflow has been omitted or otherwise incorrectly executed, a lock-out feature may disable Attorney Ref. No. BHC239009 WO both element 126 of overlay user interface 124 and element 116 of primary user interface 114. Further, overlay display device 122 and/or primary display device 112 may provide an error message as described herein, and the elements 116, 126 may be disabled until the error is corrected. [0099] As shown in FIG.4D, overlay user interface 124 of overlay display device 122 may include element 126 that is disabled such that element 126 is non-functional with regard to control functionality for fluid injector 102. As further shown in FIG.4D, primary user interface 114 may include primary user interface element 116 that corresponds to disabled element 126 of overlay user interface 124, and primary user interface element 116 may be enabled with regard to control functionality for fluid injector 102. [00100] As shown in FIG.4E, primary user interface 114 of primary display device 112 may include element 116 that is disabled such that element 116 is non-functional with regard to control functionality for fluid injector 102. As further shown in FIG.4E, overlay user interface 124 may include overlay user interface element 126 that corresponds to disabled element 116 of the primary user interface, and wherein the overlay user interface element is enabled with regard to control functionality for the fluid injector. [00101] Referring now to FIGS.5A and 5B, non-limiting embodiments of primary display device 112 and/or overlay display device 122 and primary user interface 114 and/or overlay user interface 124 of a fluid injector system are illustrated in accordance with the present disclosure. As shown in FIGS 5A and 5B, primary user interface 114 and/or overlay user interface 124 may be a graphical user interface (GUI). Further, element 116 or primary user interface 112 and/or element 126 of overlay user interface may be a GUI element. [00102] In some non-limiting embodiments, as illustrated in FIG.5B, primary user interface 114 and/or overlay user interface 124 may include one or more elements 116’, 126’ which may be physical buttons. In some non-limiting embodiments, primary user interface 114 and/or overlay user interface 124 may include both physical button elements 116’, 126’ and GUI elements 116, 126, as shown in FIG.5B. Elements 116’, 126’ of primary user interface 114 and/or overlay user interface 124, implemented in the exemplary embodiment as physical buttons, may also be enabled or disable the same or similar to elements 116, 126 of primary user interface 114 and/or overlay user interface 124 as described herein. For example, where primary display device is Attorney Ref. No. BHC239009 WO positioned with a sterile field and overlay display device is positioned outside of a sterile field, button element 116’ of primary display device 112 may be enabled to control functionality of fluid injector 102 and fluid injector system 100, such as to arm fluid injector 102 when indicated by a Guided Workflow. However, this functionality may be provided only on the primary display device, while element 126’ of overlay user interface 124 in the non-sterile field may be disabled. [00103] In some non-limiting embodiments, where primary user interface 114 and/or overlay user interface 124 include both physical button elements 116’, 126’ and GUI elements 116, 126, both physical button elements, 126’ and GUI element 126 may be disabled with regard to control functionality of fluid injector system 100. In other exemplary embodiments, physical button elements, 126’ may be enabled and GUI elements 126 may be disabled. The relationship between primary display device 112, overlay display device 122, and fluid injector 102, their positioning within or outside of a sterile field, the particular use case indicated, and the step or series of steps being executed as provided by a Guided Workflow may each separately or in conjunction determine which of the elements are enabled and which of the elements are disabled with regard to control functionality and/or input of data associated with fluid injector system 100. [00104] Referring now to FIGS. 6A-7F, FIGS. 6A-6F illustrate non-limiting embodiments of fluid injector system 100 in a first orientation and FIGS. 7A-7F illustrate non-limiting embodiments of fluid injector system 100 in a second orientation in accordance with the present disclosure. The exemplary first orientation may be an upright or set-up position, and the exemplary second orientation may be a downward or injection position. As illustrated in FIGS. 6A-7F, fluid injector system 100 may include the various devices and components described herein including fluid injector 102, primary display device 112 in communication with fluid injector 102, and primary user interface 114 which may provide control functionality. Further, fluid injector system 100 may include overlay display device 122 in communication with fluid injector 102 and primary display device 112. Overlay display device may be positioned in proximity to the fluid injector associated with fluid injector system 102, and as shown in the exemplary embodiments, overlay display device may be positioned the injector head of fluid injector 102, which may be outside of the sterile field. Overlay display device 122 may include overlay user interface 124 that provides control functionality for fluid injector 102. In some non-limiting embodiments, overlay user interface 124 Attorney Ref. No. BHC239009 WO may include one or more elements that provide the same control functionality for fluid injector 102 as one or more elements of primary user interface 114. [00105] In some non-limiting embodiments, fluid injector stem 100 may also include one or more syringes 140. As shown in FIGS.6A-6E, a fluid injector 102 and/or fluid injector system 100 may be provided in a first orientation in which a proximal end of syringes 140 point upward. Primary display device 112 may be removably attached to an articulable arm 206. Articulable arm 206 may allow primary display device to be moved to various positions in the sterile field as necessary for an injection procedure. The articulable arm may be positioned on a stand of fluid injection system 100, such as stand 204 shown in FIGS.2A and 2B. [00106] With continued reference to FIGS. 6A-7F, in some embodiments, fluid injector system 100 may include an attachment member 602. Attachment member 602 may be configured to allow for attachment of fluid injector system 100 to a free- standing pedestal or stand, or to a patient table 604 such as to rail 606 of patient table 604 as shown in FIGS.6E-6F and 7E-7F. Thus, articulable arm 206 may be positioned on rail 606 of patient table 604. [00107] In some non-limiting embodiments, overlay display device 122 may be removably attached to a second articulable arm, and the articulable arm 206 of primary display device 112 and the second articulable arm of overlay display device 122 may be attached to a common mounting point of rail 606 of patient table 604. [00108] In some non-limiting embodiments, such as where overlay display device 122 is provided on fluid injector 102, overlay display device 122 may include a sensor for sensing an orientation of fluid injector 102, and overlay display device 122 may be controlled or configured to adjust the orientation of numbers, words, and images on overlay display device 122 based on the orientation of fluid injector 102. In this way, fluid injector system 100 ensures that the overlay user interface 124 is readable by a user regardless of the orientation of fluid injector 102, and for example, displayed in an upright position. As discussed herein, the sensor for sensing orientation may be an accelerometer or another suitable sensor. The same or a similar sensor may be provided in primary display device 112 to provide the same functionality. [00109] For example, fluid injector system 100 may be provided in a first orientation as shown in FIGS.6A-6F with the proximal end of syringe(s) 140 pointing upward to allow for setup and priming of the syringes or other steps of an injection procedure. The fluid injector system may then be moved or repositioned as shown in FIGS.7A- Attorney Ref. No. BHC239009 WO 7F, in which the proximal end of syringe(s) 140 point downward in an injection position. During or after the fluid injector 102 is repositioned, the sensor may sense the movement and change in orientation of the fluid injector 102 and of overlay display device 122 and may correct the orientation of the overlay user interface 124 to ensure that the overlay user interface 124 is readable by a user and displayed in an upright position. In moving or repositioning fluid injector system 100 from the first orientation to the second orientation, the primary display device 112 may also be rotated to an inverse or “upside down” orientation. Inclusion of the same or a similar sensor in the primary display device may sense the movement and/or change in orientation, and may correct the orientation of primary user interface 114 to ensure that the primary user interface 114 is readable by a user and displayed in an upright position. In some non-limiting embodiments, element(s) may also be provide in the user interfaces for manual input of change in orientation of the display devices. In other embodiments, the user may lock the orientation of information of the primary and/or overly display devices into a desired position, for example based on personal preference. [00110] In some non-limiting embodiments, primary display device 112 may further include a sensor or be in communication with a sensor such as an accelerometer, a mechanical switch, a light sensor, a motion sensor, or the like for sensing the angle of articulation of articulable arm 206. Primary display device 112 and fluid injector system 100 may determine whether the primary display device is inside of the sterile field or outside of the sterile field based on the angle of articulation or orientation and position of the articulable arm 206. The same or a similar sensor may be provided in overlay display device 122 to provide the same functionality. Further upon determination of the positioning of primary display device 112 and overlay display device 122, regarding which display device(s) is/are within the sterile field, and which display device(s) is/are outside of the sterile field, the fluid injector system 100 and the respective display devices may initiate execution of a Guided Workflow on the respective user interface. For example, where primary display device 112 determines that primary display device 112 is located inside of the sterile field, primary user interface 114 may initiate a Guided Workflow for a display device located inside of a sterile field. In embodiments where primary display device 112 determines that primary display device 112 is located outside of the sterile field, a Guided Workflow for a display device located outside of the sterile field may be initiated on the primary user interface. Attorney Ref. No. BHC239009 WO [00111] In some non-limiting embodiments, an element of primary user interface 114 of primary display device 112 and/or an element of overlay user interface 124 of overlay display device 122 may be provided for manual input of whether the display device is located inside of the sterile field or outside of the sterile field. The manual input of whether primary display device 112 or overlay display device 122 is located inside of the sterile field or outside of the sterile field may initiate execution of a Guided Workflow on the primary user interface 114 or overlay user interface 124 based on the manual input. [00112] Referring now to FIG.8, a non-limiting embodiment of environment 800 in which a fluid injector system may be implemented is shown in accordance with the present disclosure. As shown in FIG.8, fluid injector system 100 may include one or more additional display devices, such as secondary display device 812 in communication with fluid injector system 100 and fluid injector 102. Secondary display device 812 may be provided in addition to primary display device 112 and overlay display device 122 or instead of either primary display device 112 or overlay display device 122. Further, secondary display device may be the same as or similar to primary display device 112 including primary user interface 114 having element 116 and/or overlay display device 122 including overlay user interface 124 having element 126. As previously described in association with primary display 112 and overlay display 122, certain functions and features may be associated with or disabled on secondary display device 812 according to the requirements of the particular fluid injection procedure. [00113] As illustrated, environment 800 may be a medical imaging suite, such as an angiography suite, which may be located in hospitals and/or imaging centers for use in performing imaging procedures on patients for diagnostic purposes and for interventionally treating vascular blockages. Environment 800 may include scan room 808, for example within an angiography suite, in which fluid injector system 100, fluid injector 102, and a medical imaging system are located, and control room 802 from which an operator (e.g., a Radiologist) may conduct or monitor the injection and imaging procedures, monitor the angiography procedure, and monitor a patient through one or more secondary display devices 812, such as work station devices, associated with fluid injection system 100 and/or medical imaging system 806. Control room 802 may be separated from the scan room 808, and thus be outside of the sterile field. Further, control room 802 may be considered to be outside of the sterile field, Attorney Ref. No. BHC239009 WO and outside of the non-sterile field due to the separation between control room 802 and scan room 808. Thus, secondary display device 812 may be located outside of the sterile field, and may be considered to be outside of the non-sterile field. [00114] Fluid injector system 100 may include a multi-fluid delivery system as described according to the embodiments herein. As shown in FIG. 8, secondary display device 812 may be in communication with overlay display device 122 and/or primary display device 112 used by the operator to set up and/or execute a fluid injection procedure. In some non-limiting embodiments, secondary display device 812 may provide a secondary user interface 814 (e.g., an application-based user interface, a web-based user interface, etc.) on secondary display device for control of fluid injector system 100 and medical imaging system 806. The parameters of an injection protocol of a fluid injection procedure may be inputted by the user, recalled from a common database, or automatically generated by a controller or an injection protocol management system, such as injection protocol management system 302 described herein, associated with fluid injector system 100, and, in some embodiments, displayed on secondary display device 812 and/or communicated to fluid injector system 100 for execution. [00115] Environment 800 may include fluid injector system 100 having fluid injector 102 provided on a pedestal or stand 804 mounted to a base with lockable casters affixed at the bottom for use in moving the fluid injector system 100 within scan room 808 as needed during imaging procedures. Stand 804 may also include an integrated IV pole inclusive of one or more hooks for hanging IV-related accessories. In some non-limiting embodiments, the base may house various electronic and communications components as well as the power supply for fluid injector system 100. Alternatively, as described herein, the fluid injector 102 may be attached to the patient table. As further shown in FIG.8, and as also shown in FIGS.11A-11B, fluid injector system 100 may include power cable 821 and fiber optic link 822, among other connections, which may be in communication with secondary display device 812, to enable control of the operation of fluid injector system 100 from outside of scan room 808. Other communication means, including wireless communication via WIFI, cellular, Bluetooth, and other networks of the like, may also be implemented for communication between secondary display device 812 and the other components and devices of fluid injector system 100. It is also considered that secondary display device 812 may be located in in an operating procedure room such as within scan room 808. Attorney Ref. No. BHC239009 WO In such non-limiting embodiments, secondary display device 812 may be removably attached to an articulable arm positioned on stand 804. [00116] Referring now to FIGS.9A and 9B, diagrams of non-limiting embodiments of fluid injector system 100 in accordance with the present disclosure are illustrated. As shown in FIGS.9A and 9B, fluid injector system 100 may include primary display device 112 in communication with fluid injector 102. Primary display device 112 may be located inside a sterile field and may include primary user interface 114 that provides control functionality for fluid injector 102 and fluid injector system 100. Fluid injector system 100 may further include overlay display device 122 in communication with fluid injector system 100 and in communication with primary display device 112. Overlay display device 122 may be positioned in proximity to fluid injector 102 associated with fluid injector system 100, as in FIG.9A, and may be located inside of a non-sterile field. In some non-limiting embodiments, overlay display device 122 may be positioned on fluid injector 102 associated with fluid injector system 100, as in FIG. 9B, and may be located inside of a non-sterile field. [00117] Overlay display device 122 may include overlay user interface 124 that provides control functionality for fluid injector 102 and fluid injector system 100. Overlay user interface 124 may include one or more elements 126 that provide the same control functionality for fluid injector 102 and/or fluid injector system 100 as one or more elements 116 of primary user interface 112. Fluid injector system 100 may further include secondary display device 812 in communication with primary display device 112 and in communication with overlay display device 122. Secondary display device 812 may be located outside of the sterile field, and may include secondary user interface 814, which may have one or more elements 816. [00118] As further illustrated, element 816 of secondary user interface 814, element 126 of overlay user interface 124 and element 116 of primary user interface 114 may correspond to each other such that they provide the same control functionality for fluid injector 102 and fluid injector system 100. Depending on the control functionality presented or prescribed by one of various steps in a Guided Workflow, element 816 of secondary user interface 814, element 126 of overlay user interface 124, and element 116 of primary user interface 114 may be enabled to provide the indicated control functionality, as shown in FIG. 9A. In some non-limiting embodiments, any combination of elements 816, 126, 116 of each respective user interface may be disabled with regard to control functionality, such as by being “grayed out”, covered Attorney Ref. No. BHC239009 WO (such as with diagonal lines as illustrated), or otherwise blocked out. For example, if one or more sensors of fluid injector system 100 detects that one or more components has been incorrectly installed, or a step in a series of a Guided Workflow has been omitted or otherwise incorrectly executed, a lock-out feature may disable any or all of elements 816, 126, 116 of each respective user interface. Further, any of display devices 812, 122, 112 may provide an error message as described herein, and the elements 816, 126, 116 may be disabled until the error is corrected. [00119] In some non-limiting embodiments, as shown in FIG.9B, secondary user interface 814 of secondary display device 812 may include element 816 that is disabled such that the element is non-functional with regard to control functionality for fluid injector 102 and fluid injector system 100. As further shown in FIG.9B, primary user interface 114 and overlay user interface 824 may include primary user interface element 116 and overlay user interface element 126 that correspond to disabled element 816 of secondary user interface, and primary user interface element 116 and/or overlay user interface element 126 may be enabled with regard to control functionality for fluid injector 102 and fluid injector system 102. However, it is to be understood that although some element may be disabled for a given user interface and/or may include other elements that are enabled with regard to control functionality. [00120] For example, secondary user interface 814 may have elements that are disabled with regard to arming a fluid injector or executing or real-time modification of a fluid injection protocol but may include one or more elements that are enabled such that the element is functional with regard to input of values or information of a medical fluid or of a patient relevant to an injection procedure. FIG.10 illustrates an exemplary embodiment of a user interface as a GUI which allows for input of values or information of a medical fluid or of a patient relevant to an injection procedure, which may be secondary user interface 814, primary user interface 114, or overlay user interface 124 having a user interface element 816, 126, 116 respectively. [00121] In some non-limiting embodiments, where one or more elements of a primary user interface 116 and one or more elements of an overly user interface 126 correspond with each other and are each enabled with regard to control functionality for the fluid injector or fluid injector system, different or opposing commands may be executed or different values may be inputted by different users via the primary and overlay user interfaces 116, 126. In such an instance, various lock out or override protocols may be executed. For example, in accordance with one embodiment, the Attorney Ref. No. BHC239009 WO command or value that is inputted first is the command or value that is executed or used in carrying out the procedure. In some non-limiting embodiments, the command or value that is inputted second overrides the first command or value and thus the second command or value inputted is executed or used in carrying out the procedure. In other embodiments, when different or opposing commands or values are inputted simultaneously or within a certain time period (e.g., one second to five seconds), the fluid injector system may execute a manual-command-only lock out, which may require the command to be re-entered or re-set via a physical button type element of the system. It is considered that various other lock out or override protocols may be implemented depending on the type of command or information that is being inputted. In other embodiments, priority between inputted values may be assigned according to the user interface into which the value is entered. For example, for procedure critical values priority may be given to values or input that is entered via the primary user interface 116, for example from the physician conducting the angiography procedure. Such protocols may be stored in the injection protocol management system and executed by the fluid injector system when various prescribed conditions are met. [00122] Referring now to FIGS. 11A and 11B, non-limiting embodiments of a secondary display device 812 of fluid injector system 100 and components thereof are illustrated in accordance with the present disclosure. As shown in FIGS.11A and 11B, secondary display device 812 may be a workstation device and may be located outside of the sterile field, such as in a control room. Secondary display device 812 may include secondary user interface 814, which may have one or more elements 816. Secondary display device 812 may further include one or more physical button element 816’, which may be provided on a handheld device and may be connected via a wire 1022a to secondary display device 812. In some non-limiting embodiments, physical button element 816’ may provide control functionality with regard to fluid injector 102 and fluid injector system 100. [00123] As further shown in FIGS.11A and 11B, secondary display device 812 may be in communication with a fluid injector system such as fluid injector system 100 via one or more connections. For example, fiber optic link 822 be provide a network connection for secondary display device 812 and fluid injector system 100. In some embodiments, secondary display device 812 may also be connected to a primary display device 112, an overlay display device 122, or another component or device of fluid injector system 100 via wire 1022b. As discussed herein, secondary display Attorney Ref. No. BHC239009 WO device 812 may also or instead by linked, connected to, or in communication with fluid injector system 100 or another device or component of fluid injector system 11 via wireless communication such as WIFI, cellular, Bluetooth, or other like networks. [0001] While several examples of fluid injector systems, devices, and associated components of fluid injector systems having a dual display configuration are shown in the accompanying figures and described in detail hereinabove, other aspects will be apparent to, and readily made by, those skilled in the art without departing from the scope and spirit of the disclosure. Accordingly, the foregoing description is intended to be illustrative rather than restrictive. The various embodiments of the present disclosure described hereinabove is defined by the appended claims and all changes to the disclosed concepts that fall within the meaning and range of equivalency of the claims are to be embraced within their scope. Although the above systems, methods and various embodiments and aspects thereof have been described in detail for the purpose of illustration based on what is currently considered to be the most practical and preferred embodiments, it is to be understood that such detail is solely for that purpose and that the present disclosure is not limited to the described embodiments or aspects but, to the contrary, is intended to cover modifications and equivalent arrangements that are within the spirit and scope of the present system. For example, it is to be understood that the present disclosure contemplates that, to the extent possible, one or more features of any embodiment or aspect can be combined with one or more features of any other embodiment or aspect. In fact, any of these features can be combined in ways not specifically disclosed in the specification.

Claims

Attorney Ref. No. BHC239009 WO CLAIMS WHAT IS CLAIMED IS: 1. A fluid injector system, the fluid injector system comprising: a primary display device, wherein the primary display device is located inside a sterile field of an angiography suite, wherein the primary display device comprises a primary user interface that provides control functionality for a fluid injector; and an overlay display device associated with the primary display device, wherein the overlay display device is positioned in proximity to the fluid injector of the fluid injector system, wherein the overlay display device is located outside of the sterile field, wherein the overlay display device comprises an overlay user interface that provides control functionality for the fluid injector, and wherein the overlay user interface comprises one or more elements that provide the same control functionality for the fluid injector as one or more elements of the primary user interface. 2. The fluid injector system of claim 1, wherein the overlay user interface of the overlay display device comprises at least one element that can be disabled such that the at least one element is non-functional with regard to control functionality for the fluid injector. 3. The fluid injector system of claim 1 or 2, wherein the primary user interface of the primary display device comprises at least one element that can be disabled such that the at least one element is non-functional with regard to control functionality for the fluid injector. 4. The fluid injector system of claim 1, wherein the overlay user interface of the overlay display device comprises at least one element that is disabled such that the at least one element is non-functional with regard to control functionality for the fluid injector, and the primary user interface comprises a primary user interface element that corresponds to the disabled at least one element of the overlay user interface, and wherein the primary user interface element is enabled with regard to control functionality for the fluid injector. 5. The fluid injector system of claim 1, wherein the primary user interface of the primary display device comprises at least one element that is disabled such that the Attorney Ref. No. BHC239009 WO at least one element is non-functional with regard to control functionality for the fluid injector, and the overlay user interface comprises an overlay user interface element that corresponds to the disabled at least one element of the primary user interface, and wherein the overlay user interface element is enabled with regard to control functionality for the fluid injector. 6. The fluid injector system of claim 2 or 4, wherein the overlay user interface of the overlay display device is a graphical user interface (GUI), and wherein the at least one element of the overlay user interface comprises at least one GUI element. 7. The fluid injector system of claim 3 or 5, wherein the primary user interface of the primary display device is a graphical user interface (GUI), and wherein the at least one element of the primary user interface comprises at least one GUI element. 8. The fluid injector system of claim 2 or 4, wherein the at least one element of the overlay user interface comprises at least one physical button. 9. The fluid injector system of claim 3 or 5, wherein the at least one element of the primary user interface comprises at least one physical button. 10. The fluid injector system of any one of claims 1 to 9, wherein the overlay display device is positioned on or within a range of 1 foot to 5 feet of the fluid injector. 11. The fluid injector system of any one of claims 1 to 10, wherein the overlay display device is positioned on a housing of the fluid injector and the primary display device is positioned on an articulable arm connected to a stand for the fluid injector. 12. The fluid injector system of any one of claims 1 to 11, wherein the fluid injector system further comprises a secondary display device in communication with the fluid injector. 13. A fluid injector system, the fluid injector system comprising: a fluid injector; Attorney Ref. No. BHC239009 WO a primary display device in communication with the fluid injector, wherein the primary display device comprises a primary user interface that provides control functionality for the fluid injector, wherein the primary display device is configured to be located inside or outside of a sterile field of an angiography suite; and an overlay display device in communication with the fluid injector and in communication with the primary display device, wherein the overlay display device is positioned in proximity to the fluid injector, wherein the overlay display device is located outside the sterile field, and wherein the overlay display device comprises an overlay user interface that provides control functionality for the fluid injector, wherein the overlay user interface comprises one or more elements that provide the same control functionality for the fluid injector as one or more elements of the primary user interface. 14. The fluid injector system of claim 13, wherein the primary display device is located inside of the sterile field. 15. The fluid injector system of claim 13, wherein the fluid injector system further comprises: a fluid injector housing, a stand, at least one syringe; at least one drive member; at least one administration line; and at least one controller. 16. The fluid injector system of claim 15, wherein the overlay display device is positioned on the fluid injector housing. 17. The fluid injector system of claim 16, wherein the overlay display device further comprises a sensor for sensing an orientation of the fluid injector, and wherein the overlay display device adjusts an orientation of the overlay user interface based on the orientation of the fluid injector such that the overlay user interface is readable by a user. Attorney Ref. No. BHC239009 WO 18. The fluid injector system of any one of claims 15 to 17, wherein the primary display device is removably attached to an articulable arm. 19. The fluid injector system of claim 18, wherein the articulable arm is positioned on the stand of the fluid injector system. 20. The fluid injector system of claim 18, wherein the articulable arm is positioned on a rail of a patient table. 21. The fluid injector system of claim 20, wherein the overlay display device is removably attached to a second articulable arm, and the articulable arm of the primary display device and the second articulable arm of the overlay display device are attached to a common mounting point of the rail of the patient table. 22. The fluid injector system of claim 18, wherein the primary display device further comprises a sensor for sensing the angle of articulation of the articulable arm, and wherein the sensor of the primary display device determines whether the primary display device is inside of the sterile field or outside of the sterile field based on the angle of articulation. 23. The fluid injector system of claim 22, wherein when the sensor of the primary display device determines the primary display device is located inside of the sterile field, the primary display device initiates execution of at least one guided workflow on the primary user interface for a display device located inside of a sterile field. 24. The fluid injector system of claim 22, wherein when the sensor of the primary display device determines the primary display device is located outside of the sterile field, the primary display device initiates execution of at least one guided workflow on the primary user interface for a display device located outside of a sterile field. 25. The fluid injector system of claim 18, wherein at least one element of the primary user interface of the primary display device is configured for manual input depending on whether the primary display device is located inside of the sterile field or outside of the sterile field, and wherein the manual input initiates execution of at Attorney Ref. No. BHC239009 WO least one guided workflow on the primary user interface based on the manual input depending on whether the primary display is located inside of the sterile field or outside of the sterile field. 26. A fluid injector system comprising: a primary display device in communication with a fluid injector, wherein the primary display device is located inside a sterile field, wherein the primary display device comprises a primary user interface having one or more elements that provide control functionality for the fluid injector; an overlay display device in communication with the fluid injector, wherein the overly display device is in communication with the primary display device, wherein the overlay display device is positioned in proximity to the fluid injector, wherein the overlay display device is located inside of a non-sterile field, and wherein the overlay display device comprises an overlay user interface that provides control functionality for the fluid injector, wherein the overlay user interface comprises one or more elements that provide the same control functionality for the fluid injector as the one or more elements of the primary user interface; and a secondary display device in communication with the primary display device and in communication with the overlay display device, wherein the secondary display device is located outside of the sterile field, wherein the secondary display device comprises a secondary user interface, and wherein the secondary user interface comprises one or more secondary display elements. 27. The fluid injector system of claim 26, wherein the secondary display device is located outside of the sterile field and outside of the non-sterile field. 28. The fluid injector system of claim 26 or 27, wherein at least one secondary display element of the one or more secondary display elements can be disabled such that the at least one secondary display element is non-functional with regard to control functionality for the fluid injector. 29. The fluid injector system of claim 26 or 27, wherein at least one secondary display element of the one or more secondary display elements can be disabled such that the at least one secondary display element is non-functional with regard to control Attorney Ref. No. BHC239009 WO functionality for the fluid injector, and the primary user interface comprises a primary user interface element that corresponds to the disabled at least one secondary display element, and wherein the primary user interface element is enabled with regard to control functionality for the fluid injector. 30. The fluid injector system of claim 26 or 27, wherein at least one secondary display element of the one or more secondary display elements is enabled such that the at least one secondary display element is functional with regard to input of values or information of at least one of a medical fluid, an injection parameter, and a patient relevant to an injection procedure. 31. The fluid injector system of any one of claims 26 to 30, wherein the secondary display device is located in an angiography suite. 32. The fluid injector system of any one of claims 26 to 30, wherein the secondary display device is located in a control room. 33. The fluid injector system of any one of claims 26 to 30, wherein the secondary display device is removably attached to an articulable arm and the articulable arm is positioned on a stand.